Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs HSBC Holdings plc (HSBC) Price & Performance

Axogen IncTrade
HSBC Holdings plcTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs HSBC Holdings plc — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while HSBC Holdings plc trades at $99.88 (market cap $337.30B). The key difference: HSBC Holdings plc is far larger — about 163.7× Axogen Inc's market cap, and HSBC Holdings plc pays a 3.78% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

AXGNHSBC
Market Cap
$2.06B$337.30B
Sector
TechnologyTechnology
52-Week High
$46.19$99.25
52-Week Low
$11.28$61.30
Enterprise Value
$1.98B
Dividend Yield
3.78%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.

The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.

HSBC Holdings plc

HSBC trades at $98.09, down 1.01% today but near its 52-week high of $99.47. Technical indicators show a bullish trend with strong moving average support. The bank reported $71.02B revenue and $22.29B net income for 2025, maintaining a robust 30.81% net margin. Recent news highlights strategic moves including AI partnerships with Google Cloud and potential divestitures of non-core units like its Turkey business.

HSBC presents a balanced investment case with steady profitability and strategic refocusing, but faces risks from global economic sensitivity and regulatory challenges. Analyst consensus is mixed with 38% buy ratings, suggesting cautious optimism amid execution risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About HSBC Holdings plc

HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.

Read more on HSBC